These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9814955)

  • 21. Mucosal immunization with inactivated human immunodeficiency virus plus CpG oligodeoxynucleotides induces genital immune responses and protection against intravaginal challenge.
    Dumais N; Patrick A; Moss RB; Davis HL; Rosenthal KL
    J Infect Dis; 2002 Oct; 186(8):1098-105. PubMed ID: 12355360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Active and passive immunization against oral Candida albicans infection in a murine model.
    Farah CS; Ashman RB
    Oral Microbiol Immunol; 2005 Dec; 20(6):376-81. PubMed ID: 16238599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques.
    Miyake A; Akagi T; Enose Y; Ueno M; Kawamura M; Horiuchi R; Hiraishi K; Adachi M; Serizawa T; Narayan O; Akashi M; Baba M; Hayami M
    J Med Virol; 2004 Jul; 73(3):368-77. PubMed ID: 15170630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human immunodeficiency virus type 1 Gag-specific vaginal immunity and protection after local immunizations with sindbis virus-based replicon particles.
    Vajdy M; Gardner J; Neidleman J; Cuadra L; Greer C; Perri S; O'Hagan D; Polo JM
    J Infect Dis; 2001 Dec; 184(12):1613-6. PubMed ID: 11740739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution and quantification of human immunodeficiency virus type 1, strain JC499, proviral DNA in tissues from an infected chimpanzee.
    Wei Q; Javadian A; Lausen N; Fultz PN
    Virology; 2000 Oct; 276(1):59-69. PubMed ID: 11021995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzee.
    Youn JW; Park SH; Lavillette D; Cosset FL; Yang SH; Lee CG; Jin HT; Kim CM; Shata MT; Lee DH; Pfahler W; Prince AM; Sung YC
    Hepatology; 2005 Dec; 42(6):1429-36. PubMed ID: 16317673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutralizing activity and cellular immune responses induced in mice after immunization with apoptotic HIV-1/murine leukemia virus infected cells.
    Hinkula J; Walther-Jallow L; Laurén A; Mäkitalo B; Oberg M; Wahren B; Fenyö EM; Spetz AL
    Vaccine; 2009 Oct; 27(46):6424-31. PubMed ID: 19549607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fc receptor but not complement binding is important in antibody protection against HIV.
    Hessell AJ; Hangartner L; Hunter M; Havenith CE; Beurskens FJ; Bakker JM; Lanigan CM; Landucci G; Forthal DN; Parren PW; Marx PA; Burton DR
    Nature; 2007 Sep; 449(7158):101-4. PubMed ID: 17805298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The first successful AIDS vaccine: immunization of chimpanzees confers protection against challenge with human immunodeficiency virus.
    Moor-Jankowski J
    J Med Primatol; 1991; 20(1):47-8. PubMed ID: 2051469
    [No Abstract]   [Full Text] [Related]  

  • 30. Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells.
    Fultz PN; Nara P; Barre-Sinoussi F; Chaput A; Greenberg ML; Muchmore E; Kieny MP; Girard M
    Science; 1992 Jun; 256(5064):1687-90. PubMed ID: 1609280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genital infection of female chimpanzees with human immunodeficiency virus type 1.
    Girard M; Mahoney J; Wei Q; van der Ryst E; Muchmore E; Barré-Sinoussi F; Fultz PN
    AIDS Res Hum Retroviruses; 1998 Oct; 14(15):1357-67. PubMed ID: 9788677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody-dependent enhancement of human immunodeficiency virus type 1 (HIV-1) infection in vitro by serum from HIV-1-infected and passively immunized chimpanzees.
    Robinson WE; Montefiori DC; Mitchell WM; Prince AM; Alter HJ; Dreesman GR; Eichberg JW
    Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4710-4. PubMed ID: 2471977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current issues in the development of a vaccine against HIV infection.
    Davey RT
    Ear Nose Throat J; 1990 Jul; 69(7):497-505. PubMed ID: 2205474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of HIV-I IIIB infection in chimpanzees by CD4 immunoadhesin.
    Dis Markers; 1991; 9(6):339-41. PubMed ID: 1823314
    [No Abstract]   [Full Text] [Related]  

  • 35. Failure of a human immunodeficiency virus (HIV) immune globulin to protect chimpanzees against experimental challenge with HIV.
    Prince AM; Horowitz B; Baker L; Shulman RW; Ralph H; Valinsky J; Cundell A; Brotman B; Boehle W; Rey F
    Proc Natl Acad Sci U S A; 1988 Sep; 85(18):6944-8. PubMed ID: 3413127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Virus infections: strategies of prevention.
    Deinhardt F
    Behring Inst Mitt; 1992 Apr; (91):28-37. PubMed ID: 1524569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Present status of vaccination against HIV-1 infection.
    Girard M
    Int J Immunopharmacol; 1995 Feb; 17(2):75-8. PubMed ID: 7657409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of HIV infection by passive immunization with HIVIG or CD4-IgG.
    Eichberg JW; Murthy KK; Ward RH; Prince AM
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1515. PubMed ID: 1466993
    [No Abstract]   [Full Text] [Related]  

  • 39. Experimental studies on passive immunization against poliomyelitis. III. Passive-active immunization and pathogenesis after virus feeding in chimpanzees.
    BODIAN D
    Am J Hyg; 1953 Jul; 58(1):81-100. PubMed ID: 13065275
    [No Abstract]   [Full Text] [Related]  

  • 40. Preventing sexual transmission of HSV and HIV: the challenge for active and passive immunization of mucosal surfaces.
    Zeitlin L; Palmer C; Whaley KJ
    Biotechnol Genet Eng Rev; 2002; 19():121-38. PubMed ID: 12520875
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.